Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.

I call it my AI Retirement Playbook. I recommend you check it out now.

ORMP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Oramed Pharmaceuticals Insider Trading History Chart

Oramed Pharmaceuticals Share Price & Price History

^$2.33

▼ -0.04 (-1.69%)

As of 12/30/2024 06:30 PM ET

Days: 30 | 90 | 365

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Oramed Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/16/2023	Nadav Kidron	CEO	Buy	26,000	$2.04	$53,040.00	126,000
3/14/2023	Nadav Kidron	CEO	Buy	100,000	$2.01	$201,000.00	100,000
3/13/2023	Yadin Rozov	Director	Buy	20,000	$1.96	$39,200.00	36,500
1/3/2023	Michael Rabinowitz	Insider	Sell	13,325	$12.55	$167,228.75	126,143
3/21/2022	Kevin Rakin	Director	Sell	10,000	$9.41	$94,100.00

WARNING: “Buffett Indicator” flashing for first time in 50 years

From Behind the Markets | Ad

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

SEC Filings (Institutional Ownership Changes) for Oramed Pharmaceuticals (NASDAQ:ORMP)

12.73% of Oramed Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Oramed Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2024	XTX Topco Ltd	24,716	$60K	0.0%	+59.7%	0.061%
11/15/2024	Murchinson Ltd.	1,708,879	$4.17M	1.1%	+0.5%	4.239%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	111,519	$0.27M	0.0%	N/A	0.274%
11/5/2024	BML Capital Management LLC	2,186,191	$5.33M	3.1%	+62.1%	5.362%
8/16/2024	Murchinson Ltd.	1,699,990	$4.37M	0.7%	+23.2%	4.184%
8/14/2024	Squarepoint Ops LLC	81,758	$0.21M	0.0%	-8.3%	0.201%
8/14/2024	Murchinson Ltd.	874,992	$2.25M	0.4%	-36.6%	2.154%
8/12/2024	XTX Topco Ltd	15,474	$40K	0.0%	N/A	0.038%
8/9/2024	Renaissance Technologies LLC	230,800	$0.59M	0.0%	+89.0%	0.568%
8/9/2024	Dimensional Fund Advisors LP	31,470	$81K	0.0%	+52.1%	0.077%
5/20/2024	Virtu Financial LLC	23,165	$68K	0.0%	N/A	0.057%
5/16/2024	Murchinson Ltd.	1,379,495	$4.03M	0.3%	+31.4%	3.395%
4/24/2024	Assenagon Asset Management S.A.	18,659	$54K	0.0%	N/A	0.046%
4/23/2024	BML Capital Management LLC	844,496	$2.47M	1.6%	-33.1%	2.084%
1/30/2024	BML Capital Management LLC	1,261,559	$2.91M	2.2%	+61.5%	3.127%
11/13/2023	Algert Global LLC	14,680	$38K	0.0%	N/A	0.036%
11/13/2023	Rathbones Group PLC	289,803	$0.76M	0.0%	N/A	0.718%
11/7/2023	Barclays PLC	18,406	$47K	0.0%	+39.0%	0.046%
11/6/2023	N.E.W. Advisory Services LLC	12,960	$34K	0.0%	N/A	0.032%
10/23/2023	BML Capital Management LLC	781,292	$2.04M	1.9%	-8.1%	1.940%
9/21/2023	Barclays PLC	13,239	$47K	0.0%	-35.9%	0.033%
8/7/2023	Acadian Asset Management LLC	31,736	$0.11M	0.0%	N/A	0.079%
7/26/2023	Glass Jacobson Investment Advisors llc	12,255	$44K	0.0%	N/A	0.031%
7/24/2023	BML Capital Management LLC	850,000	$3.04M	2.7%	-37.3%	2.123%
5/12/2023	Corsair Capital Management L.P.	47,256	$0.10M	0.0%	N/A	0.119%
4/18/2023	ETF Managers Group LLC	68,940	$0.15M	0.0%	N/A	0.173%
4/14/2023	BML Capital Management LLC	1,355,925	$2.96M	2.6%	N/A	3.409%
2/14/2023	683 Capital Management LLC	20,537	$0.25M	0.0%	N/A	0.052%
2/13/2023	GSA Capital Partners LLP	46,039	$0.55M	0.1%	N/A	0.118%
2/9/2023	Landscape Capital Management L.L.C.	26,220	$0.32M	0.0%	N/A	0.067%
2/9/2023	Citigroup Inc.	65,890	$0.79M	0.0%	+115.0%	0.168%
2/8/2023	Belpointe Asset Management LLC	29,900	$0.36M	0.0%	N/A	0.076%
2/8/2023	Russell Investments Group Ltd.	56,516	$0.68M	0.0%	N/A	0.144%
2/6/2023	Glass Jacobson Investment Advisors llc	9,350	$0.11M	0.1%	N/A	0.024%
2/1/2023	Private Portfolio Partners LLC	53,600	$0.65M	0.2%	-20.5%	0.137%
2/1/2023	Janney Montgomery Scott LLC	12,379	$0.15M	0.0%	N/A	0.032%
1/26/2023	Calamos Advisors LLC	14,746	$0.18M	0.0%	N/A	0.038%
1/25/2023	Lindbrook Capital LLC	383,351	$4.61M	0.6%	N/A	0.980%
1/18/2023	Private Advisor Group LLC	11,794	$0.14M	0.0%	N/A	0.030%
11/15/2022	ETF Managers Group LLC	94,493	$0.61M	0.0%	+8.2%	0.242%
11/14/2022	Cubist Systematic Strategies LLC	117,477	$0.76M	0.0%	+66.1%	0.303%
11/14/2022	Ergoteles LLC	24,149	$0.16M	0.0%	-89.3%	0.062%
11/10/2022	Phoenix Holdings Ltd.	13,634	$89K	0.0%	-73.2%	0.035%
11/7/2022	Virtu Financial LLC	21,526	$0.14M	0.0%	-19.3%	0.055%
11/7/2022	Private Portfolio Partners LLC	67,400	$0.44M	0.1%	+24.8%	0.174%
11/3/2022	Barclays PLC	21,543	$0.14M	0.0%	+8.7%	0.055%
10/31/2022	SG Americas Securities LLC	10,370	$67K	0.0%	-77.7%	0.027%
10/21/2022	Morgan Jess S & Co. Inc.	366,401	$2.37M	2.1%	+16.2%	0.944%
10/17/2022	Cambridge Investment Research Advisors Inc.	14,184	$92K	0.0%	+26.8%	0.037%
8/15/2022	Laurion Capital Management LP	12,393	$57K	0.0%	N/A	0.032%
8/13/2022	Virtu Financial LLC	26,661	$0.12M	0.0%	N/A	0.069%
8/11/2022	Bank of Montreal Can	249,200	$1.35M	0.0%	N/A	0.646%
8/8/2022	Oppenheimer & Co. Inc.	50,000	$0.23M	0.0%	+5.4%	0.130%
8/2/2022	Private Portfolio Partners LLC	54,010	$0.25M	0.1%	+27.8%	0.140%
7/29/2022	SG Americas Securities LLC	46,532	$0.21M	0.0%	N/A	0.121%
7/21/2022	Belvedere Trading LLC	40,690	$0.34M	0.0%	N/A	0.106%
7/19/2022	Commonwealth Equity Services LLC	29,514	$0.14M	0.0%	+7.1%	0.077%
7/18/2022	Morgan Jess S & Co. Inc.	315,301	$1.44M	1.5%	+8.5%	0.818%
7/13/2022	Cambridge Investment Research Advisors Inc.	11,184	$51K	0.0%	N/A	0.029%
6/30/2022	Amalgamated Bank	6,457	$56K	0.0%	N/A	0.017%
5/16/2022	Morgan Jess S & Co. Inc.	290,501	$2.51M	1.8%	+34.9%	0.759%
5/12/2022	Private Portfolio Partners LLC	42,250	$0.37M	0.1%	N/A	0.110%
5/12/2022	Oppenheimer & Co. Inc.	47,450	$0.41M	0.0%	+18.6%	0.124%
5/10/2022	Phoenix Holdings Ltd.	28,155	$0.24M	0.0%	-10.1%	0.074%
5/9/2022	Rossmore Private Capital	40,661	$0.35M	0.1%	-21.8%	0.106%
5/9/2022	Qube Research & Technologies Ltd	56,348	$0.49M	0.0%	-13.0%	0.147%
5/5/2022	Russell Investments Group Ltd.	43,013	$0.37M	0.0%	-55.7%	0.112%
5/3/2022	Calamos Advisors LLC	38,071	$0.33M	0.0%	-65.9%	0.099%
4/25/2022	Assenagon Asset Management S.A.	385,413	$3.33M	0.0%	N/A	1.007%
4/21/2022	Strs Ohio	5,400	$46K	0.0%	-41.9%	0.014%
3/3/2022	Walleye Capital LLC	36,740	$0.53M	0.0%	N/A	0.096%
2/14/2022	Point72 Hong Kong Ltd	2,132	$30K	0.0%	N/A	0.006%
2/14/2022	ETF Managers Group LLC	53,153	$0.73M	0.0%	+6.5%	0.139%
2/14/2022	Rockefeller Capital Management L.P.	4,000	$57K	0.0%	N/A	0.010%
2/11/2022	Renaissance Technologies LLC	203,200	$2.90M	0.0%	N/A	0.531%
2/10/2022	Qube Research & Technologies Ltd	64,799	$0.93M	0.0%	N/A	0.169%
2/10/2022	OLD Mission Capital LLC	38,691	$0.55M	0.0%	N/A	0.101%
2/10/2022	HighTower Advisors LLC	14,000	$0.20M	0.0%	-50.0%	0.037%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	50,786	$0.73M	0.0%	+96.4%	0.133%
2/9/2022	BNP Paribas Arbitrage SA	20,266	$0.29M	0.0%	+275.9%	0.053%
2/9/2022	UMB Bank N A MO	8,080	$0.12M	0.0%	N/A	0.021%
2/8/2022	Swiss National Bank	64,400	$0.92M	0.0%	N/A	0.168%
2/8/2022	Northern Trust Corp	243,125	$3.47M	0.0%	+7.7%	0.635%
2/7/2022	Victory Capital Management Inc.	13,310	$0.19M	0.0%	N/A	0.035%
2/7/2022	SG Americas Securities LLC	8,631	$0.12M	0.0%	-36.3%	0.023%
2/7/2022	Phoenix Holdings Ltd.	31,328	$0.44M	0.0%	+9.5%	0.082%
2/7/2022	Rossmore Private Capital	52,004	$0.74M	0.1%	+10.6%	0.136%
2/3/2022	Advisor Group Holdings Inc.	26,267	$0.38M	0.0%	+49.5%	0.069%
2/2/2022	New York State Common Retirement Fund	22,545	$0.32M	0.0%	+25.5%	0.059%
2/2/2022	Oppenheimer & Co. Inc.	40,000	$0.57M	0.0%	+14.9%	0.104%
2/1/2022	Zurcher Kantonalbank Zurich Cantonalbank	7,706	$0.11M	0.0%	N/A	0.020%
2/1/2022	Calamos Advisors LLC	111,519	$1.59M	0.0%	-15.6%	0.291%
2/1/2022	Qube Research & Technologies Ltd	64,799	$0.93M	0.0%	N/A	0.169%
1/28/2022	Allspring Global Investments Holdings LLC	68,317	$0.98M	0.0%	N/A	0.178%
1/27/2022	Janney Montgomery Scott LLC	23,260	$0.33M	0.0%	+13.6%	0.061%
1/27/2022	Morgan Jess S & Co. Inc.	215,401	$3.08M	1.9%	+0.7%	0.563%
1/21/2022	Russell Investments Group Ltd.	97,110	$1.39M	0.0%	-5.6%	0.254%
12/8/2021	Moors & Cabot Inc.	435,000	$0.44M	0.0%	N/A	1.142%
11/17/2021	Altium Capital Management LP	493,384	$12.63M	2.8%	N/A	1.517%
11/15/2021	Man Group plc	37,285	$0.82M	0.0%	+170.2%	0.115%

Data available starting January 2016

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules for delivery of polypeptides. The company's product portfolio includes ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes, as well as in phase II clinical trial for the treatment of non-alcoholic steatohepatitis; and ORA-D-013-1 and ORA-D-013-2, which have completed phase II clinical trial for the treatment of type 2 diabetes. It has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.

Today's Range

Now: $2.33

$2.33

$2.40

50 Day Range

MA: $2.37

$2.17

$2.52

52 Week Range

Now: $2.33

$2.00

$3.67

Volume

213,027 shs

Average Volume

139,321 shs

Market Capitalization

$93.93 million

P/E Ratio

21.18

Dividend Yield

N/A

Beta

1.7

Who are the company insiders with the largest holdings of Oramed Pharmaceuticals?: Oramed Pharmaceuticals' top insider investors include:
Michael Rabinowitz (Insider)
Nadav Kidron (CEO)
Yadin Rozov (Director)
Learn More about top insider investors at Oramed Pharmaceuticals.

Most People Are Dead Wrong.

From Brownstone Research | Ad